Bioabsorbable ureteral stents: current state-of-the-art
https://doi.org/10.21886/2308-6424-2024-12-2-76-86
Abstract
Ureteral stenting is one of the main methods for draining the upper urinary tract. The main drawbacks associated with the use of ureteral stents include high treatment costs, stent-associated symptoms, "forgotten" ureteral stents, encrustation, and polymer recycling after stent removal. Biodegradable ureteral stents may be solution for mentioned problems, offering several advantages: (1) avoidance of stent removal, reducing invasion procedures and health costs; (2) prevention of "forgotten" stents; (3) improvement of quality of life; (4) reduction in carbon footprint. This article presents a literature review of the recent developments in biodegradable stent technology.
About the Authors
A. A. AloyanRussian Federation
Aram A. Aloyan — M.D., Urologist, Urology Department, Pirogov Clinic of Advanced Medical Technologies (SPSU Hospital) — St. Petersburg State University; Postgrad. Student, Dept. of Urology, St. Petersburg State University
Saint-Petersburg
Competing Interests:
The authors declare no conflicts of interest.
I. A. Gorgotsky
Russian Federation
Ivan A. Gorgotsky — M.D., Cand.Sc.(Med); Assoc.Prof., Dept. of Urology, St. Petersburg State University; Urologist, Urology Department, Pirogov Clinic of Advanced Medical Technologies (SPSU Hospital) — St. Petersburg State University
Saint-Petersburg
Competing Interests:
The authors declare no conflicts of interest.
N. S. Korbina
Russian Federation
Natalia S. Korbina — Resident, Urology Department, Pirogov Clinic of Advanced Medical Technologies (SPSU Hospital) — St. Petersburg State University
Saint-Petersburg
Competing Interests:
The authors declare no conflicts of interest.
V. P. Britov
Russian Federation
Vladislav P. Britov — Dr.Sc. (Engineering), Full Prof., Head, Dept. of Equipment and Technology of Plastics Processing, St. Petersburg State Institute of Technology (Technical University)
Saint-Petersburg
Competing Interests:
The authors declare no conflicts of interest.
I. V. Semenyakin
Russian Federation
Igor V. Semenyakin — M.D., Dr.Sc.(Med); MEDSI Clinical and Diagnostic Centre
Moscow
Competing Interests:
The authors declare no conflicts of interest.
D. D. Shkarupa
Russian Federation
Dmitry D. Shkarupa — M.D., Dr.Sc.(Med); Director, Pirogov Clinic of Advanced Medical Technologies (SPSU Hospital) — St. Petersburg State University; Prof., Dept. of Urology, St. Petersburg State University
Saint-Petersburg
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
N. K. Gadzhiev
Russian Federation
Nariman K. Gadzhiev — M.D., Dr.Sc.(Med); Deputy CEO for Medical Care Management (Urology), Pirogov Clinic of Advanced Medical Technologies (SPSU Hospital) — St. Petersburg State University; Prof., Dept. of Urology, St. Petersburg State University
Saint-Petersburg
Competing Interests:
Авторы заявляют об отсутствии конфликта интересов.
References
1. Finney RP. Experience with new double J ureteral catheter stent. J Urol. 1978;120(6):678-681. DOI: 10.1016/s0022-5347(17)57326-7
2. Ambani SN, Faerber GJ, Roberts WW, Hollingsworth JM, Wolf JS Jr. Ureteral stents for impassable ureteroscopy. J Endourol. 2013;27(5):549-553. DOI: 10.1089/end.2012.0414
3. Chen H, Pan Y, Xiao M, Yang J, Wei Y. The Outcomes of Pre-Stenting on Renal and Ureteral Stones: A Meta-Analysis. Urol Int. 2022;106(5):495-503. DOI: 10.1159/000519473
4. Law YXT, Teoh JYC, Castellani D, Lim EJ, Chan EOT, Wroclawski M, Pirola GM, Giulioni C, Rubilotta E, Gubbioti M, Scarcella S, Chew BH, Traxer O, Somani BK, Gauhar V. Role of pre-operative ureteral stent on outcomes of retrograde intra-renal surgery (RIRS): systematic review and meta-analysis of 3831 patients and comparison of Asian and non-Asian cohorts. World J Urol. 2022;40(6):1377-1389. DOI: 10.1007/s00345-022-03935-2
5. Harber M. Practical Nephrology. London: Springer; 2014. DOI: 10.1007/978-1-4471-5547-8
6. Connelly ZM, Stolzle A, Vanlangendonck RA, Price WJ 3rd, Morgan K, Khater N. Ureteral stenting in the clinic: a safe and cost-effective alternative to the operating room. Am J Clin Exp Urol. 2023;11(4):304-311. PMID: 37645614
7. Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents. Urology. 2002;59(4):511-516. DOI: 10.1016/s0090-4295(01)01644-2
8. Miyaoka R, Monga M. Ureteral stent discomfort: Etiology and management. Indian J Urol. 2009;25(4):455-460. DOI: 10.4103/0970-1591.57910
9. Chew BH, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. Curr Opin Urol. 2004;14(2):111-115. DOI: 10.1097/00042307-200403000-00011
10. Haleblian G, Kijvikai K, de la Rosette J, Preminger G. Ureteral stenting and urinary stone management: a systematic review. J Urol. 2008;179(2):424-430. DOI: 10.1016/j.juro.2007.09.026
11. Thomas R. Indwelling ureteral stents: impact of material and shape on patient comfort. J Endourol. 1993;7(2):137-140. DOI: 10.1089/end.1993.7.137
12. Davenport K, Kumar V, Collins J, Melotti R, Timoney AG, Keeley FX Jr. New ureteral stent design does not improve patient quality of life: a randomized, controlled trial. J Urol. 2011;185(1):175-178. DOI: 10.1016/j.juro.2010.08.089
13. Small AC, Thorogood SL, Shah O, Healy KA. Emerging Mobile Platforms to Aid in Stone Management. Urol Clin North Am. 2019;46(2):287-301. DOI: 10.1016/j.ucl.2018.12.010
14. Gleeson MJ, Glueck JA, Feldman L, Griffith DP, Noon GP. Comparative in vitro encrustation studies of biomaterials in human urine. ASAIO Trans. 1989;35(3):495-498. DOI: 10.1097/00002480-198907000-00104
15. Zahran MH, Harraz AM, Taha DE, El-Nahas AR, Elshal A, Shokeir AA. Studying the Morbidity and Renal Function Outcome of Missed Internal Ureteral Stents: A Matched Pair Analysis. J Endourol. 2015;29(9):1070-1075. DOI: 10.1089/end.2015.0047
16. Lopes Neto AC. Forgotten Double-J Ureteral Stent. Int Braz J Urol. 2019;45(6):1087-1089. DOI: 10.1590/S1677-5538.IBJU.2019.06.02
17. Singh I, Gupta NP, Hemal AK, Aron M, Seth A, Dogra PN. Severely encrusted polyurethane ureteral stents: management and analysis of potential risk factors. Urology. 2001;58(4):526-531. DOI: 10.1016/s0090-4295(01)01317-6
18. Ziemba JB, Ludwig WW, Ruiz L, Carvalhal E, Matlaga BR. Preventing the Forgotten Ureteral Stent by Using a Mobile Point-of-Care Application. J Endourol. 2017;31(7):719-724. DOI: 10.1089/end.2017.0118
19. Sancaktutar AA, Tepeler A, Söylemez H, Penbegül N, Atar M, Bozkurt Y, Yıldırım K. A solution for medical and legal problems arising from forgotten ureteral stents: initial results from a reminder short message service (SMS). Urol Res. 2012;40(3):253-258. DOI: 10.1007/s00240-011-0404-8
20. Ulker V, Atalay HA, Cakmak O, Yucel C, Celik O, Kozacioglu Z. Smartphone-based stent tracking application for prevention of forgotten ureteral double-J stents: a prospective study. Int Braz J Urol. 2019;45(2):376-383. DOI: 10.1590/S1677-5538.IBJU.2018.0707
21. Molina WR, Pessoa R, Donalisio da Silva R, Kenny MC, Gustafson D, Nogueira L, Leo ME, Yu MK, Kim FJ. A new patient safety smartphone application for prevention of "forgotten" ureteral stents: results from a clinical pilot study in 194 patients. Patient Saf Surg. 2017;11:10. DOI: 10.1186/s13037-017-0123-3
22. Becker B, Gadzhiev N, Popiolek M, Gross AJ, Netsch C. Smartphone-App für Patienten mit Nierensteinen [A mobile app for patients suffering from kidney stones]. Urologe A. 2018;57(5):577-582. (In German). DOI: 10.1007/s00120-018-0652-0
23. Ghani KR, Rojanasarot S, Cutone B, Bhattacharyya SK, Krambeck AE. Economic burden of complicated ureteral stent removal in patients with kidney stone disease in the USA. J Comp Eff Res. 2022;11(17):1253-1261. DOI: 10.2217/cer-2022-0153
24. Gadzhiev N, Brovkin S, Grigoryev V, Dmitriev V, Korol V, Shkarupa D, Pisarev A, Tagirov N, Malkhasyan V, Semeniakin I, Khromov-Borisov N, Petrov S. Ultrasound-Guided Ureteral Stent Removal in Women. J Ultrasound Med. 2016;35(10):2159-2163. DOI: 10.7863/ultra.15.11028
25. Robinson PN, Surendran K, Lim SJ, Robinson M. The carbon footprint of surgical operations: a systematic review update. Ann R Coll Surg Engl. 2023;105(8):692-708. DOI: 10.1308/rcsann.2023.0057
26. Zhu Y, Yang K, Cheng R, Xiang Y, Yuan T, Cheng Y, Sarmento B, Cui W. The current status of biodegradable stent to treat benign luminal disease. Materials Today. 2017;20(9):516-529. DOI: 10.1016/j.mattod.2017.05.002
27. Zong X, Ran S, Kim KS, Fang D, Hsiao BS, Chu B. Structure and morphology changes during in vitro degradation of electrospun poly(glycolide-co-lactide) nanofiber membrane. Biomacromolecules. 2003;4(2):416-423. DOI: 10.1021/bm025717o
28. Li G, Wang ZX, Fu WJ, Hong BF, Wang XX, Cao L, Xu FQ, Song Q, Cui FZ, Zhang X. Introduction to biodegradable polylactic acid ureteral stent application for treatment of ureteral war injury. BJU Int. 2011;108(6):901-906. DOI: 10.1111/j.1464-410X.2010.09992.x
29. Lumiaho J, Heino A, Kauppinen T, Talja M, Alhava E, Välimaa T, Törmälä P. Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expanding X-raypositive poly-L,D-lactide spiral partial ureteral stent: an experimental study. J Endourol. 2007;21(12):1559-1564. DOI: 10.1089/end.2005.0085
30. Wolters HH, Heistermann HP, Stöppeler S, Hierlemann H, Spiegel HU, Palmes D. A new technique for ureteral defect lesion reconstruction using an autologous vein graft and a biodegradable endoluminal stent. J Urol. 2010;184(3):1197-1203. DOI: 10.1016/j.juro.2010.04.072
31. Fu WJ, Wang ZX, Li G, Cui FZ, Zhang Y, Zhang X. Comparison of a biodegradable ureteral stent versus the traditional double-J stent for the treatment of ureteral injury: an experimental study. Biomed Mater. 2012;7(6):065002. DOI: 10.1088/1748-6041/7/6/065002
32. Soria F, de la Cruz JE, Budia A, Serrano A, Galan-Llopis JA, Sanchez-Margallo FM. Experimental Assessment of New Generation of Ureteral Stents: Biodegradable and Antireflux Properties. J Endourol. 2020;34(3):359-365. DOI: 10.1089/end.2019.0493
33. Soria F, de La Cruz JE, Caballero-Romeu JP, Pamplona M, Pérez-Fentes D, Resel-Folskerma L, Sanchez-Margallo FM. Comparative assessment of biodegradable-antireflux heparine coated ureteral stent: animal model study. BMC Urol. 202;21(1):32. DOI: 10.1186/s12894-021-00802-x
34. Soria F, Morcillo E, Serrano A, Budia A, Fernández I, Fernández-Aparicio T, Sanchez-Margallo FM. Evaluation of a New Design of Antireflux-biodegradable Ureteral Stent in Animal Model. Urology. 2018;115:59-64. DOI: 10.1016/j.urology.2018.02.004
35. Soria F, Aznar-Cervantes SD, de la Cruz JE, Budia A, Aranda J, Caballero JP, Serrano Á, Sánchez Margallo FM. Assessment of a Coated Mitomycin-Releasing Biodegradable Ureteral Stent as an Adjuvant Therapy in Upper Urothelial Carcinoma: A Comparative In Vitro Study. Polymers (Basel). 2022;14(15):3059. DOI: 10.3390/polym14153059
36. Ruggieri MR, Hanno PM, Levin RM. Reduction of bacterial adherence to catheter surface with heparin. J Urol. 1987;138(2):423-426. DOI: 10.1016/s0022-5347(17)43177-6
37. Cauda F, Cauda V, Fiori C, Onida B, Garrone E. Heparin coating on ureteral Double J stents prevents encrustations: an in vivo case study. J Endourol. 2008;22(3):465-472. DOI: 10.1089/end.2007.0218
38. Soria F, de La Cruz JE, Budia A, Cepeda M, Álvarez S, Serrano Á, Sanchez-Margallo FM. Iatrogenic Ureteral Injury Treatment with Biodegradable Antireflux Heparin-Coated Ureteral Stent-Animal Model Comparative Study. J Endourol. 2021;35(8):1244-1249. DOI: 10.1089/end.2020.0591
39. Hadaschik BA, Paterson RF, Fazli L, Clinkscales KW, Shalaby SW, Chew BH. Investigation of a novel degradable ureteral stent in a porcine model. J Urol. 2008;180(3):1161-1166. DOI: 10.1016/j.juro.2008.05.003
40. Chew BH, Lange D, Paterson RF, Hendlin K, Monga M, Clinkscales KW, Shalaby SW, Hadaschik BA. Next generation biodegradable ureteral stent in a yucatan pig model. J Urol. 2010;183(2):765-771. DOI: 10.1016/j.juro.2009.09.073
41. Chew BH, Paterson RF, Clinkscales KW, Levine BS, Shalaby SW, Lange D. In vivo evaluation of the third generation biodegradable stent: a novel approach to avoiding the forgotten stent syndrome. J Urol. 2013;189(2):719-725. DOI: 10.1016/j.juro.2012.08.202
42. Gao L, Liu X, Xu M, Sun G, Xu S, Zou T, Wang L, Wang F, Da J, Wang Y, Wang L. Biodegradable Anti-Biofilm Fiber-Membrane Ureteral Stent Constructed with a Robust Bio-mimetic Superhydrophilic Polycationic Hydration Surface Exhibiting Synergetic Antibacterial and Antiprotein Properties. Small. 2021;17(20):e2006815. DOI: 10.1002/smll.202006815
43. Lingeman JE, Schulsinger DA, Kuo RL. Phase I trial of a temporary ureteral drainage stent. J Endourol. 2003;17(3):169-171. DOI: 10.1089/089277903321618734
44. Lingeman JE, Preminger GM, Berger Y, Denstedt JD, Gold-stone L, Segura JW, Auge BK, Watterson JD, Kuo RL. Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. J Urol. 2003;169(5):1682-1688. DOI: 10.1097/01.ju.0000055600.18515.a1
45. Olweny EO, Landman J, Andreoni C, Collyer W, Kerbl K, Onciu M, Välimaa T, Clayman RV. Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. J Urol. 2002;167(5):2198-2202. PMID: 11956478
46. Zhang MQ, Zou T, Huang YC, Shang YF, Yang GG, Wang WZ, Zhou JM, Wang L, Chen F, Xie H. Braided thin-walled biodegradable ureteral stent: preliminary evaluation in a canine model. Int J Urol. 2014;21(4):401-407. DOI: 10.1111/iju.12297
47. Yang G, Xie H, Huang Y, Lv Y, Zhang M, Shang Y, Zhou J, Wang L, Wang JY, Chen F. Immersed multilayer biodegradable ureteral stent with reformed biodegradation: An in vitro experiment. J Biomater Appl. 2017;31(8):1235-1244. DOI: 10.1177/0885328217692279
48. Zhang Y, Wang L, Wang Y, Li L, Zhou J, Dou D, Wu Z, Yu L, Fan Y. Degradable Antimicrobial Ureteral Stent Construction with Silver@graphdiyne Nanocomposite. Adv Healthc Mater. 2023;12(26):e2300885. DOI: 10.1002/adhm.202300885
49. Tie D, Liu H, Guan R, Holt-Torres P, Liu Y, Wang Y, Hort N. In vivo assessment of biodegradable magnesium alloy ureteral stents in a pig model. Acta Biomater. 2020;116:415-425. DOI: 10.1016/j.actbio.2020.09.023.
50. Barros AA, Oliveira C, Ribeiro AJ, Autorino R, Reis RL, Duarte ARC, Lima E. In vivo assessment of a novel biodegradable ureteral stent. World J Urol. 2018;36(2):277-283. DOI: 10.1007/s00345-017-2124-3
51. Jin L, Yao L, Yuan F, Dai G, Xue B. Evaluation of a novel biodegradable ureteral stent produced from polyurethane and magnesium alloys. J Biomed Mater Res B Appl Biomater. 2021;109(5):665-672. DOI: 10.1002/jbm.b.34730
52. Zhang Y, He J, Chen H, Xiong C. A new hydrophilic biodegradable ureteral stent restrain encrustation both in vitro and in vivo. J Biomater Appl. 2021;35(6):720-731. DOI: 10.1177/0885328220949376
Review
For citations:
Aloyan A.A., Gorgotsky I.A., Korbina N.S., Britov V.P., Semenyakin I.V., Shkarupa D.D., Gadzhiev N.K. Bioabsorbable ureteral stents: current state-of-the-art. Urology Herald. 2024;12(2):76-86. (In Russ.) https://doi.org/10.21886/2308-6424-2024-12-2-76-86